GENOSCO : /Yuhan Announce Results from Phase 1/2 Study of YH25448, a 3rd-Generation EGFR-TKI, in Advanced NSCLC to be Presented at ASCO 2018

Press/Media: Press / Media

Period2018 May 16

Media coverage

1

Media coverage